Video

Expert Discusses Surgical Implications of a BRCA Mutation

Author(s):

William J Gradishar, M.D.

William J. Gradishar, M.D., discusses the potential surgical implications for a woman with breast cancer who tests positive for a BRCA mutation, and why it is important to be aware of this genetic information.

William J. Gradishar, M.D., chief of hematology and oncology in the Department of Medicine and Betsy Bramsen Professor of Breast Oncology at Northwestern University Feinberg School of Medicine, discusses the potential surgical implications for a woman with breast cancer who tests positive for a BRCA mutation, and why it is important to be aware of this genetic information.

Women with BRCA mutations have a higher chance of both breast and ovarian cancer. So, women may want to consider a bilateral mastectomy, even if the breast cancer only occurs on one side, to prevent a recurrence. Surgical removal of the ovaries may also be considered, to drastically decrease the chance of developing ovarian cancer.

Related Videos
Image of a woman with tied back hair, wearing pearl earrings.
Image of a woman with layered hair, wearing a bright blue cardigan.
Image of a man with short black hair.
Image of man with gray hair.
Image of woman with black hair.
Image of a man wearing a black suit and tie.
Image of a man with white hair and a white goatee.
Image of a woman with brown wavy hair, wearing a navy blue top.
Image of a man wearing a suit with a red bowtie.
Related Content
Illustration of a woman with short brown hair.
October 15th 2024

International Flat Day, a Breast Cancer Celebration

Bonnie Annis
When I underwent surgery for breast cancer, reconstruction was highly recommended, but I decided to remain flat — a decision I think about sometimes.
cancer horizons logo: a white microphone on a navy blue background
March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
Illustration of a woman with shoulder-length gray hair, wearing glasses.
October 14th 2024

From Survivor to Survivors: Best Wishes for Recovering From a Storm

Felicia Mitchell
When natural disasters come, they affect everybody, including people dealing with cancer. I hope for speedy recoveries to patients affected by Hurricane Helene.
FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment
February 5th 2024

FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment

Alex Biese Brielle Benyon
One cancer vaccine may still be years away from being available, a breast cancer test may be misguiding treatments for Black women and the review of two oncology regimens are being expedited by the FDA.
Image of FDA Approved.
Published: October 10th 2024 | Updated: October 11th 2024

FDA Approves Itovebi Combo for Some With Advanced Breast Cancer

Alex Biese
The Food and Drug Administration (FDA) has approved Itovebi (inavolisib) with Ibrance (palbociclib) and Faslodex (fulvestrant) for certain patients with advanced or metastatic breast cancer.
Image of breast cancer cells.
October 10th 2024

Dato-DXd May Improve Progression-Free Survival in Breast Cancer Subset

Spencer Feldman
For a subset of patients with inoperable or metastatic HR-positive/HER2-negative breast cancer, treatment with datopotamab deruxtecan improved progression-free survival.